255 related articles for article (PubMed ID: 31146120)
21. Cell cycling in HIV infection: analysis of in vivo activated lymphocytes.
Mahalingam M; Pozniak A; McManus TJ; Vergani D; Peakman M
Clin Exp Immunol; 1995 Dec; 102(3):481-6. PubMed ID: 8536361
[TBL] [Abstract][Full Text] [Related]
22. Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers.
Anand A; Dean GS; Quereshi K; Isenberg DA; Lydyard PM
Lupus; 2002; 11(8):493-500. PubMed ID: 12220103
[TBL] [Abstract][Full Text] [Related]
23. Intravenous immunoglobulin therapy enhances suppressive regulatory T cells and decreases innate lymphoid cells in children with immune thrombocytopenia.
Wang SC; Yang KD; Lin CY; Huang AY; Hsiao CC; Lin MT; Tsai YG
Pediatr Blood Cancer; 2020 Feb; 67(2):e28075. PubMed ID: 31736241
[TBL] [Abstract][Full Text] [Related]
24. [Levels of regulatory T cells in peripheral blood of children with idiopathic thrombocytopenic purpura].
Wang XP; Qiu YS; Hao GP; Zhu L
Zhongguo Dang Dai Er Ke Za Zhi; 2011 Apr; 13(4):282-4. PubMed ID: 21507294
[TBL] [Abstract][Full Text] [Related]
25. [Role of CD4(+) CD25(high) T cells in the pathogenesis of idiopathic thrombocytopenic purpura].
Shu MM; Cao XM; Zhang WG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):875-7. PubMed ID: 18718081
[TBL] [Abstract][Full Text] [Related]
26. Participation of B-cell-activating factor receptors in the pathogenesis of immune thrombocytopenia.
Min YN; Wang CY; Li XX; Hou Y; Qiu JH; Ma J; Shao LL; Zhang X; Wang YW; Peng J; Hou M; Shi Y
J Thromb Haemost; 2016 Mar; 14(3):559-71. PubMed ID: 26749059
[TBL] [Abstract][Full Text] [Related]
27. CD4
Piersiala K; Farrajota Neves da Silva P; Hjalmarsson E; Kolev A; Kågedal Å; Starkhammar M; Elliot A; Marklund L; Margolin G; Munck-Wikland E; Kumlien Georén S; Cardell LO
Cancer Sci; 2021 Mar; 112(3):1048-1059. PubMed ID: 33462898
[TBL] [Abstract][Full Text] [Related]
28. Coexpression of CD69 and HLADR activation markers on synovial fluid T lymphocytes of patients affected by rheumatoid arthritis: a three-colour cytometric analysis.
Afeltra A; Galeazzi M; Sebastiani GD; Ferri GM; Caccavo D; Addessi MA; Marcolongo R; Bonomo L
Int J Exp Pathol; 1997 Oct; 78(5):331-6. PubMed ID: 9462230
[TBL] [Abstract][Full Text] [Related]
29. The abnormal function of CD39
Lu Y; Cheng L; Li F; Ji L; Shao X; Wu B; Zhan Y; Liu C; Min Z; Ke Y; Sun L; Chen H; Cheng Y
Ann Hematol; 2019 Aug; 98(8):1845-1854. PubMed ID: 31154474
[TBL] [Abstract][Full Text] [Related]
30. Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease.
Wakiguchi H; Hasegawa S; Suzuki Y; Kudo K; Ichiyama T
Pediatr Res; 2015 Apr; 77(4):536-40. PubMed ID: 25580740
[TBL] [Abstract][Full Text] [Related]
31. Effect of mycophenolate mofetil therapy on lymphocyte activation in heart transplant recipients.
Weigel G; Griesmacher A; Karimi A; Zuckermann AO; Grimm M; Mueller MM
J Heart Lung Transplant; 2002 Oct; 21(10):1074-9. PubMed ID: 12398872
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of IVIG response in relation to Th1/Th2 cytokines in pediatricm immune thrombocytopenia.
Chen YY; Zhou YQ; Zhao N; Zhang Y; Xu WQ; Tang YM
Cytokine; 2019 Aug; 120():234-241. PubMed ID: 31129375
[TBL] [Abstract][Full Text] [Related]
33. Study of T-cell activation in type I diabetic patients and pre-type I diabetic subjects by cytometric analysis: antigen expression defect in vitro.
Giordano C; De Maria R; Todaro M; Stassi G; Mattina A; Richiusa P; Galluzzo G; Pantó F; Galluzzo A
J Clin Immunol; 1993 Jan; 13(1):68-78. PubMed ID: 8095271
[TBL] [Abstract][Full Text] [Related]
34. B-cell-activating factor, a proliferation inducing ligand and co-stimulatory molecules in the pathogenesis of immune thrombocytopenia in childhood.
Gözmen S; Karapnar TH; Tüfekçi Ö; Vergin C; Yüksel F; İrken G; Ören H
Blood Coagul Fibrinolysis; 2016 Jul; 27(5):494-9. PubMed ID: 24911453
[TBL] [Abstract][Full Text] [Related]
35. Expression of activation antigens CD69, HLA-DR, interleukin-2 receptor-alpha (IL-2R alpha) and IL-2R beta on T cells of human decidua at an early stage of pregnancy.
Saito S; Nishikawa K; Morii T; Narita N; Enomoto M; Ichijo M
Immunology; 1992 Apr; 75(4):710-2. PubMed ID: 1592443
[TBL] [Abstract][Full Text] [Related]
36. Identification of predictive factors for response to intravenous immunoglobulin treatment in children with immune thrombocytopenia.
Morimoto Y; Yoshida N; Kawashima N; Matsumoto K; Kato K
Int J Hematol; 2014; 99(5):597-602. PubMed ID: 24573984
[TBL] [Abstract][Full Text] [Related]
37. Contributions of T lymphocyte abnormalities to therapeutic outcomes in newly diagnosed patients with immune thrombocytopenia.
Zhao Z; Yang L; Yang G; Zhuang Y; Qian X; Zhou X; Xiao D; Shen Y
PLoS One; 2015; 10(5):e0126601. PubMed ID: 25978334
[TBL] [Abstract][Full Text] [Related]
38. Expression of lymphocyte activation markers of preterm neonates is associated with perinatal complications.
Sava F; Toldi G; Treszl A; Hajdú J; Harmath Á; Tulassay T; Vásárhelyi B
BMC Immunol; 2016 Jun; 17(1):19. PubMed ID: 27328920
[TBL] [Abstract][Full Text] [Related]
39. Increased ADAM10 expression in patients with immune thrombocytopenia.
Qiao J; Luo Q; Liu N; Wei G; Wu X; Lu J; Tang K; Wu Y; Zi J; Li X; Liu Y; Ju W; Qi K; Yan Z; Li Z; Zeng L; Xu K
Int Immunopharmacol; 2018 Feb; 55():63-68. PubMed ID: 29223855
[TBL] [Abstract][Full Text] [Related]
40. Immune Status and Chemokine C Receptor 7 Expression in Primary in Patients with Immune Thrombocytopenia.
Zhang L; Zhou GZ; Feng WY; Li D
Turk J Haematol; 2022 Feb; 39(1):29-37. PubMed ID: 34445858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
